Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.
Journal: The New England journal of medicine
Published: March 25, 2026
Case Report: Unique immunotherapy response in a patient with metachronous colorectal cancer not associated with Lynch Syndrome.
Journal: Frontiers in oncology
Published: June 24, 2025
ECOG-ACRIN E6293: Phase II Study of Raltitrexed in Advanced Colorectal Cancer.
Journal: The oncologist
Published: June 16, 2025
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 31, 2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.
Journal: The oncologist
Published: March 19, 2025
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.
Journal: Investigational new drugs
Published: November 06, 2024
Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy.
Journal: JNCI cancer spectrum
Published: September 08, 2024
Examining the impact of specialty palliative care consultation in patients with metastatic pancreatic cancer: evaluating use at an NCI designated cancer center.
Journal: Annals of palliative medicine
Published: August 16, 2024
Retraction: CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2024
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
Journal: Journal of the National Cancer Institute
Published: December 23, 2023
Multiplexed immunohistochemical analysis of the immune microenvironment of biliary tract cancers pre- & post-neoadjuvant chemotherapy: case series.
Journal: Annals of translational medicine
Published: November 18, 2023
Last Updated: 09/26/2026